Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung CancerMohammadhadi Khorrami, Anant Madabhushi, Prateek Prasanna et al.|Cancer Immunology Research|2019Cited by 313
Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockadePranjal Vaidya, Anant Madabhushi, Kaustav Bera et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 121
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumabKhalid Jazieh, Anant Madabhushi, Vidya Sankar Viswanathan et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 57
A tumor vasculature–based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitorsMehdi Alilou, Anant Madabhushi, Mohammadhadi Khorrami et al.|Science Advances|2022Cited by 41
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple CancersNathaniel Braman, Anant Madabhushi, Prateek Prasanna et al.|Clinical Cancer Research|2022Cited by 41